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Abstract
Background.—Alaska Native children have high invasive pneumococcal disease (IPD) rates, 
and lack of in-home running water has been shown to have a significant association with infection. 
Pneumococcal conjugate vaccines reduced IPD; however, this population saw substantial 
replacement disease and colonization with nonvaccine serotypes. We evaluated risk factors for 
nasopharyngeal pneumococcal colonization in Alaska Native adults and children.
Methods.—We conducted annual surveys from 2008 through 2011 of residents of all ages in 8 
rural Alaskan villages. Interviews were conducted, medical charts were reviewed, and 
nasopharyngeal swabs were cultured for Streptococcus pneumoniae. Multivariate logistic 
regression models were developed for 3 age groups (under 10 years, 10–17 years, and 18 years 
and older) to determine risk factors for colonization.
Results.—We obtained 12 535 nasopharyngeal swabs from 4980 participants. Our population 
lived in severely crowded conditions, and 48% of households lacked in-home running water. In 
children <10 years, colonization was associated with lack of in-home running water, household 
crowding, and more children in the home. Pneumococcal vaccination status was not associated 
with colonization. In older children and adults, increased number of persons in the household was 
associated with pneumococcal colonization.
Conclusions.—Higher colonization prevalence may partially explain increased IPD rates seen in 
those lacking in-home water services. Improving availability of sanitation services and reducing 
household crowding may reduce the burden of IPD in this population.
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Invasive disease caused by Streptococcus pneumoniae is a major cause of mortality in 
children throughout the world, and it is a leading etiology of pneumonia, meningitis, 
bacteremia, and otitis media. Nasopharyngeal colonization with this pathogen is common, 
especially in children [1–12]. Colonization is a precursor to invasive disease, and colonized 
persons can transmit pneumococci to household and community members through 
respiratory droplets.
Alaska Native (AN) children have a high incidence of invasive pneumococcal disease (IPD) 
with rates up to 426 cases per 100 000 rural children under 5 per year in 2005–2007 [13–
17]. A lack of in-home running water has been associated with increased risk of infection in 
the rural population [17–19]. Vaccination with heptavalent pneumococcal conjugate vaccine 
(PCV7) reduced overall rates of invasive disease in AN people [20], with virtual elimination 
of disease caused by vaccine serotypes. In the years after introduction of the vaccine, 
however, AN children under age 2 experienced more significant replacement disease with 
nonvaccine serotypes than other populations, principally due to serotypes 19A and 7F [20]. 
The same nonvaccine serotypes were increasingly found colonizing the nasopharynx [2, 21, 
22], highlighting the role of pneumococcal colonization in transmission of pathogenic 
serotypes causing invasive disease. The 13-valent PCV (PCV13), which was introduced to 
Alaska in 2010, includes some of the more common replacement serotypes and may reduce 
IPD rates further.
To better understand the dynamics of pneumococcal colonization in the AN population, we 
conducted a study to determine significant socioeconomic and demographic risk factors for 
pneumococcal colonization.
METHODS
Study Population
As of 2010, there are 138 312 people of at least partial AN descent, comprising 19.4% of 
Alaska’s population [23]. This diverse group includes Aleut, Athabascan, Yup’ik Eskimo, 
Tlingit, and others. The majority of AN people live in rural villages only accessible by 
airplane, boat, and snowmobile. Most receive healthcare through the AN health system—a 
statewide, tribally operated system with village clinics, regional hospitals, and tertiary care 
facilities in Anchorage. Alaska Native people have access to this system free of charge. 
Economic opportunity in villages is variable and largely depends on the presence of fishing 
and other natural resource industries. Uneven distribution of in-home water service is due to 
technical and engineering factors.
Study Design
We conducted an observational, cross-sectional survey of pneumococcal colonization in 8 
rural Alaskan villages in 3 regions: Yukon-Kuskokwim (YK), Norton Sound, and Bristol 
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Bay. Approval was obtained from village tribal elders, and villages were visited annually 
from March to April, 2008 to 2011. Approximately 2500 participants of all ages were 
invited to enroll by a mailing 2 weeks before and a radio announcement on visit days. 
Participants had to reside in a village for at least 3 weeks. Written informed consent was 
obtained from each adult and 1 parent of participating children, and written assent was 
obtained from children age 7–18 years. The study was approved by the Institutional Review 
Boards of the US Centers for Disease Control and Prevention, the Alaska Area Indian 
Health Service, and the involved regions’ tribal health boards.
Demographic and socioeconomic information was obtained through interviews, medical 
records were reviewed for recent infection and antibiotic usage, and each participant 
underwent a nasopharyngeal swab. Nasopharyngeal swabs were immersed in skim-milk 
tryptone glucose glycerol (STGG) medium and transported on ice packs to the Arctic 
Investigations Program laboratory in Anchorage, where 50 μL of the STGG specimens were 
plated onto trypticase soy agar supplemented with 5% sheep blood and 10 μg/mL 
gentamicin (Remel; Lexana, Kansas). The agar plates were incubated in 5% CO2 at 35°C–
37°C for 18–24 hours. Pneumococci were identified by colony morphology, susceptibility to 
optochin (>14 mm for 6 mm disk), and bile solubility. The outcome measured was 
nasopharyngeal colonization with pneumococcus regardless of serotype.
Statistical Analysis
Data for this study were double-entered into Paradox for Windows (Borland International, 
Scotts Valley, CA), and analyses were performed using Epi-Info and SAS version 9.3 (SAS 
Institute, Cary, NC). Because age was a strong modifier of pneumococcal colonization and 
IPD, we divided the population into 3 age groups for analysis: under 10 years, 10–17 years, 
and ≥18 years. For univariate analyses, the likelihood-ratio χ2 test was used to test 
categorical covariates, and the Cochran-Armitage trend test was used for ordinal covariates. 
Logistic regression was used for development of multivariate models. We tested for an 
association between pneumococcal colonization and household size (number of persons 
living in the home), the number of rooms in a home, and household crowding (number of 
persons per room in a home) in univariate analyses. Because of the induced collinearity, only 
household size and household crowding were considered in the multivariate models. Age 
was treated as a categorical covariate in all statistical models. Because sample sizes allowed, 
the initial multivariate model included all covariates. The best-fit regression model was 
determined by non-automatic backward selection using the strategy described by Hosmer 
and Lemeshow [24]. Study year was included in all models. The 95% confidence intervals 
(CIs) were used for all odds ratios (ORs). For the analysis of prevalence by village and 
region, village A and Bristol Bay were chosen as references because colonization prevalence 
in each was respectively close to the median of prevalence ranges.
RESULTS
Demographics
Between 2008 and 2011, we collected 12 669 nasopharyngeal swabs; 70% of village 
residents participated. We excluded 134 swabs due to incomplete culture or demographic 
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data. A total of 12 535 swabs from 4980 participants between age 4 days and 92 years were 
included in the analysis. Overall, 49% of participants were female and 99.3% were of AN 
heritage (Table 1). Children from 3 to 59 months of age had an up-to-date vaccination rate of 
83.9% with a PCV [25]. In this population, 52% of participants had in-home running water, 
and the median crowding index was 1.5 persons per room. On average, households had 5 
persons living in them with a mean of 2.1 adults ≥18 years of age. Within the previous 90 
days, 25.4% of participants received antibiotics and 35.5% of participants had a respiratory 
infection.
Risk Factors for Pneumococcal Colonization
Overall, 4155 of 12 535 (33.2%) swabs grew pneumococcus. Colonization prevalence 
peaked at age 4 years (71.8%) and then declined progressively, reaching 9.5% in adults over 
age 65 years (Figure 1). In children <10 years of age (Table 2), colonization over all 4 years 
and all 8 villages was 62.5%, ranging from a low of 37.1% (village D, 2009) to a high of 
77.4% (village C, 2011). In children age 10–17 years (Table 3), 40.1% were colonized, 
ranging from a low of 23.5% (village A, 2010) to a high of 61.7% (village E, 2010). In 
adults (Table 4), 14.3% were colonized, ranging from a low of 7.2% (village E, 2008) to a 
high of 29.2% (village E, 2010). On multivariate analysis, increased age was associated with 
lower colonization prevalence in all 3 age groups (P < .0001 for each age group), whereas no 
association was found with sex in any of the age groups (P > .37 for all) or with vaccination 
status in children under age 5 years (P = .14). In children under 5 years of age in all villages, 
65% of those who were adequately vaccinated with PCV carried pneumococcus, similar to 
65% among children who were not adequately vaccinated.
Colonization prevalence varied by region and by village in all ages. On univariate analysis, 
children under age 18 years living in the YK region had 50% higher colonization odds than 
those living in Bristol Bay. Living in village F in the YK delta was associated with increased 
colonization prevalence in this same age group on univariate analysis, but not in adults. On 
multivariate analysis, this significant association with village F persisted only in those age 
10–17 years. In village D in Norton Sound, children under age 10 years had half the odds (P 
< .0001) and adults had two-thirds the odds of colonization (P = .005) when compared to 
similar-age participants in reference village A in Bristol Bay. Multivariate analysis also 
showed a significant association between living in village H in the YK delta and increased 
prevalence in children aged 10–17 years (OR, 1.43; 95% CI, 1.03–1.99), but an association 
was not found in children under 10 years or adults.
Lack of in-home running water was associated with significantly increased colonization 
prevalence in children <10 years of age on multivariate analyses (OR, 1.35; 95% CI, 1.08–
1.69). This association was stronger when analysis was restricted to children age under 5 
years (OR, 1.42) (data not shown). There was no association on univariate or multivariate 
analyses between colonization and in-home running water in children aged 10–17 years or 
adults.
A higher number of household occupants was associated with increased colonization odds in 
all ages on univariate analysis. Having more than 3 children under 10 years old in a 
household also increased colonization odds for all ages on univariate analysis. On 
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multivariate analysis, a significant association with number of household occupants persisted 
only in children age 10–17 years and adults (OR = 1.06 and 1.05, respectively). A significant 
association with having more than 3 young children in a household persisted only for 
children under age 10 years (OR, 1.47; 95% CI, 1.22–1.77). This result means that in this 
youngest age group, those living in a household with 3 or more other small children had 
47% higher colonization odds than those living with less than 3 other young children.
On univariate analysis, increased household crowding was associated with increased 
colonization prevalence in all ages, whereas the number of rooms in a household had a 
negative association with colonization prevalence for children under 10 years and children 
10–17 years. On multivariate analysis, a significant association between colonization and 
household crowding persisted only for children under 10 years (OR = 1.11 per each 
additional person/room; 95% CI, 1.03–1.20). The number of rooms was not included in the 
multivariate model.
Antibiotic therapy within the previous 90 days was associated with reduced colonization 
prevalence in all ages on univariate and multivariate analyses. For children under age 10, 
having had otitis media, streptococcal pharyngitis, or pneumonia within the previous 90 days 
was associated with decreased colonization prevalence on univariate analysis. On 
multivariate analysis, a negative association remained only with otitis media (OR, .79; 95% 
CI, .64–.97). Also on multivariate analysis, increased colonization in adults was associated 
with having had bronchitis or a skin infection.
DISCUSSION
Alaska Native people living in rural communities have high rates of IPD and a high 
prevalence of pneumococcal nasopharyngeal colonization. We evaluated risk factors for 
colonization and found that increased prevalence in children under 10 years of age is 
independently associated with younger age, lack of in-home running water, increased 
household crowding, and a higher number of young children in the household. Factors 
associated with reduced colonization prevalence in this age group are recent antibiotic 
therapy, recent otitis media, and a higher number of rooms in the household. Among persons 
10–17 years of age and adults, colonization was associated with living with a larger number 
of people, whereas reduced colonization was associated with recent antibiotic therapy.
This population is colonized early in life, with 54% of children under 6 months old carrying 
pneumococcus. This finding is similar to what has been seen in other populations [1, 3, 4, 7, 
8, 26]. In this population, prevalence peaked at age 4 years, whereas other populations 
showed prevalence peaks at younger ages (generally from 6 months to 2 years) [1, 6, 8, 10, 
11]. The peak colonization prevalence in our study was also later than the peak rates of IPD, 
which are highest in AN children at 12 months of age (Arctic Investigations Program, 
unpublished data). The reason for this discrepancy is not known, and the mechanism by 
which nasopharyngeal pneumococcal colonization leads to invasive disease is incompletely 
understood. It is possible that colonized younger children are more at risk of invasive disease 
than colonized older children.
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Colonization prevalence was 14% in adults in this study, which is higher than in a Swedish 
adult population (0.8%) [27] and lower than in Australian Aboriginal adults (26%) [12]. 
Mackenzie et al. [12] showed an increase in colonization prevalence with age in Australian 
Aboriginal people older than 35 years; however, our study showed a steady decline in 
colonization with age (Figure 1).
In a previous study in this population, we showed that IPD risk among children under 5 
years of age is more than twice as high in villages where <10% of households have in-home 
water service compared to villages where ≥80% households have running water, after 
adjusting for household crowding and income [17]. In houses without in-home water 
service, water must be hauled by hand and is conserved for use in cooking and dish washing 
[28]. We postulated that water rationing in these households decreases opportunities for 
handwashing, especially in smaller children who need assistance, and leads to increased 
transmission of pneumococci among household members. Higher rates of other infections 
where hand or body hygiene can reduce risk (Staphylococcus aureus skin infections, viral 
infections of the lower respiratory tract) have been demonstrated in rural Alaska populations 
that lack adequate in-home water supplies [17–19, 29]. This is the first study, to our 
knowledge, to assess the relationship between in-home running water and pneumococcal 
colonization. The finding of 35% higher odds of colonization among children without in-
home running water supports the hypothesis that access to in-home running water could 
reduce IPD in this population.
We hypothesize that lack of in-home running water had no association with colonization in 
adolescents and adults because of age-related differences in hygiene practices. As children 
grow, they may initiate handwashing more frequently due to fewer physical barriers, access 
to water at school, and hygiene education. Younger children are most vulnerable to 
colonization and infection, and they are the least likely to wash their hands, making them 
ideal disseminators of pneumococci within households and communities. This tendency of 
children to disseminate the bacterium once colonized also likely explains a reduction in 
adult IPD following routine vaccination of children with PCVs [30]. Our data suggest that a 
protective effect of in-home running water may be strongest in the youngest age group. 
These data help reinforce the need to achieve universal access to in-home running water to 
reduce health disparities in this population. Still, the colonization prevalence of 61% in 
children in homes with running water is very high for a developed country, and we consider 
other factors as well to explain the high rates of IPD in rural Alaska.
The AN population in this study lived in severely crowded conditions, defined as 1.5 or 
more persons per room. This study adds to the literature showing a link between household 
crowding and pneumococcal colonization [26, 31, 32]. Outbreaks of pneumococcus are 
uncommon but typically occur in facilities with close living conditions, such as medical 
wards, prisons, and military barracks. Crowding results in more physical contact that 
enhances pneumococcal transmission. In our population, increased household crowding was 
found to be associated with (1) increased colonization in all ages on univariate analysis and 
(2) in children under age 10 years on multivariate analysis. Likewise, colonization 
prevalence increases with increasing number of household occupants and decreases with 
increasing number of rooms in a household. Having more children in a household is 
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associated with increased colonization prevalence for all ages, which reflects the importance 
of young children as potential transmitters of pneumococcus.
Our data showed no association between vaccination and overall colonization prevalence, 
which is consistent with previous data [2, 21, 22]. We saw a negative association between 
recent antibiotics and pneumococcal colonization, which has been demonstrated in many 
other studies [1, 2, 21, 33, 34]. Children <10 years of age who recently had otitis media, 
streptococcal pharyngitis, or pneumonia had lower odds of colonization. This reduction is 
likely the effect of antibiotic therapy prescribed for these infections. It is interesting to note 
that recent respiratory tract infections of typically viral etiology (viral pharyngitis, upper 
respiratory tract infection, bronchitis, and bronchiolitis) had no association with decreased 
colonization prevalence, perhaps suggesting that antibiotic therapy was appropriately limited 
to infections only of likely bacterial origin.
We found overall higher prevalence of colonization in the YK delta compared to other 
regions, which correlates with the higher IPD rates in this region. Children under age 2 
living in this region have higher IPD rates than AN children in other regions and experienced 
more replacement disease after vaccination than elsewhere in Alaska [17]. We were unable 
to explain the differences in colonization prevalence between villages in our study; however, 
the data suggest that these differences are real rather than temporary fluctuations in 
colonization. For children and adolescents living in village F, colonization prevalence was 
among the highest of all villages in most years, whereas for the same age groups living in 
village D, colonization prevalence was among the lowest of all villages in most years. A 
significant proportion of households in both villages F and D lacked access to in-home 
running water, suggesting that the cause of this persistent disparity in prevalence was not 
measured in our study. These differences may also reflect introduction of new pneumococcal 
types, variability in nasopharyngeal swabbing technique, or issues related to the 
transportation of samples from villages to the laboratory in Anchorage.
The generalizability of our results may be limited by the study population of rural AN 
persons, who have significant differences in lifestyle, household crowding, and living 
conditions from the general US population. This was also a convenience sample that tended 
to draw households with more people overall, more children, and less in-home running 
water. When proportions of in-home running water in our sample were compared with 
unpublished data for each village, our participants tended to be less likely to have in-home 
running water than the village averages. Thus, the overall prevalence of colonization from 
this study may be somewhat higher than the actual prevalence in these regions. This result is 
consistent with an analysis of this surveillance population in the past [35], which showed 
bias toward households with more children and more frequent clinic visits. The large sample 
sizes in this analysis provided high power to detect relatively small effect sizes. The 
epidemiological significance of a 5% difference in pneumococcal colonization prevalence is 
not completely understood. Furthermore, income and education levels of parents may play a 
role in village of residence, hygiene habits, and household crowding; however, these 
socioeconomic risk factors were not assessed in this study.
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The main findings of this study highlight the importance of improving living standards for 
AN populations. Providing universal in-home water service may be a way to improve 
hygiene and reduce pneumococcal colonization and infection, especially in younger 
children. For villages with water services limited by technical geographic difficulties, this 
process may require experimentation with individual household water purifiers that allow 
recycling of waste water. Reducing crowding through education and housing innovations 
may also reduce colonization and disease rates.
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Figure 1. 
Overall prevalence of nasopharyngeal pneumococcal carriage by age group, rural Alaska 
villages, 2008–2011.
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Table 1.
Demographics and Carriage Rates of the Population Studied
Number (% of Total)
Total swabs 12 535 (100%)
Colonized 4155 (33.2%)
Female 6133 (49%)
Alaska Native 12 421 (99.3%)
Age
 <6 mo 126 (1.0%)
 6–11 mo 187 (1.5%)
 12–23 mo 358 (2.9%)
 2–4 years 1032 (8.2%)
 5–9 years 1714 (13.7%)
 10–14 years 1721 (13.7%)
 15–17 years 942 (7.5%)
 18–49 years 4839 (38.6%)
 50–64 years 1136 (9.1%)
 >65 years 480 (3.8%)
In-home running water
 No 6023 (48%)
Household crowding (no. of people/no. of rooms in the house)
 Mean 1.5
Percentage of children age 3–59 months up-to-date on pneumococcal vaccination
1389 (83.9%)
Region
 Bristol Bay 1649 (13.2%)
 YK Delta 7724 (61.7%)
 Norton Sound 3162 (25.2%)
Recent Infection (previous 90 d)
 Respiratorya 4454 (35.5%)
 Skin 438 (3.5%)
 Urinary tract 249 (2.0%)
Recent systemic antibiotic use 3188 (25.4%)
a
Includes otitis media, viral pharyngitis, upper respiratory tract infection, strep throat, pneumonia, bronchitis, and bronchiolitis.
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